OCC 0.00% 36.5¢ orthocell limited

Stem Cell Therapy advancements, page-365

  1. 1,381 Posts.
    lightbulb Created with Sketch. 227
    Please have another read, this revenue has nothing to do with the Stiate+ licensing deal, it’s for all products sold for that quarter, running costs were a little higher due to increasing the size of Striate+ facility, up too 100 thousand units per year, ten more people were employed to make this happen.
    This information just popped up on my screen this morning
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
36.5¢
Change
0.000(0.00%)
Mkt cap ! $76.49M
Open High Low Value Volume
37.0¢ 37.0¢ 36.5¢ $3.871K 10.56K

Buyers (Bids)

No. Vol. Price($)
6 31535 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 4244 1
View Market Depth
Last trade - 16.10pm 21/08/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.